|
⚲
|
| Keyboard |
| Arch Venture Fund X LP
✚
|
|
|---|---|
| CIK # | 0001757011 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001757011] | |
| 4 | [0001757011] | |
| D | [0001757011] | |
| SC 13G | [0001757011] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2025-10-27 | Buy | 1,915,700 | $2.61 | 4,999,977 |
|
Prime Medicine Inc PRME
Common Stock
|
2025-08-01 | Buy | 3,030,300 | $3.30 | 9,999,990 |
|
Prime Medicine Inc PRME
Common Stock
|
2024-02-15 | Buy | 3,200,000 | $6.25 | 20,000,000 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 727,272 | $5.50 | 3,999,996 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 727,272 | $5.50 | 3,999,996 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 363,637 | $5.50 | 2,000,004 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 1,176,593 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 703,061 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 2,124,143 | ||
|
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
|
2023-09-19 | Conversion | 1,144,973 | ||
|
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
|
2023-09-19 | Conversion | 684,167 | ||
|
Neumora Therapeutics Inc NMRA
Series B Preferred Stock · derivative
|
2023-09-19 | Conversion | 2,124,143 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 684,167 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 1,144,973 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 6,895,021 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 6,576,400 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Buy | 1,500,000 | $17.00 | 25,500,000 |
|
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
|
2023-09-19 | Conversion | 6,895,021 | ||
|
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
|
2023-09-19 | Conversion | 6,576,400 | ||
|
Prime Medicine Inc PRME
Common Stock
|
2022-10-24 | Buy | 400,000 | $17.00 | 6,800,000 |
| showing 20 of 69 most recent transactions | |||||